Effects of diazepam on extracellular brain neurotransmitters in pilocarpine-induced seizures in rats

European Journal of Pharmacology

Volumn 373, Issue 2-3, 1999, Pages 153-161

  Khan, Ghous M ^a   Smolders, Ilse ^a   Lindekens, Hilde ^a   Manil, Jacqueline ^a   Ebinger, Guy ^a   Michotte, Yvette ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Cerebellum; Diazepam; Dopamine; Electrocorticography; GABA ( aminobutyric acid); Glutamate; Hippocampus; Microdialysis; Pilocarpine

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; DIAZEPAM; DOPAMINE; GLUTAMIC ACID; NEUROTRANSMITTER; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CEREBELLUM; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DIALYSATE; ELECTROCORTICOGRAPHY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CEREBELLUM; DIAZEPAM; DOPAMINE; ELECTROENCEPHALOGRAPHY; EXTRACELLULAR SPACE; GABA MODULATORS; GAMMA-AMINOBUTYRIC ACID; GLUTAMATES; HIPPOCAMPUS; MALE; NEUROTRANSMITTER AGENTS; PILOCARPINE; RATS; RATS, WISTAR; SEIZURES;

EID: 0033019135     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00209-5     Document Type: Article

References (57)

1. 3H ] glutamate in rat hippocampal slices J. Neurochem. 40:1983;280-284.
2. Benardo L.S., Prince D.A. Ionic mechanisms of cholinergic excitation of mammalian hippocampal pyramidal cells. Brain Res. 249:1982;315-331.
3. Bernasconi R., Klein M., Martin P.et al. The specific protective effect of diazepam and valproate against isoniazid-induced seizures is not correlated with increased GABA levels. J. Neural Transm. 63(2):1985;169-189.
4. A channels in rat dentate gyrus. J. Membr. Biol. 142:1994;93-102.
5. Carlson H., Ronne-Engström E., Ungerstedt U., Hillered I. Seizure related elevations of extracellular amino acids in human focal epilepsy. Neurosci. Lett. 140:1992;30-32.
6. Cavalheiro E.A., Leite J.P., Bortolotto Z.A., Turski W.A., Ikonomidou-Turski C., Turski L. Long term effects of pilocarpine in rat structural damage of the brain triggers kindling and spontaneously recurrent seizures. Epilepsia. 32:1991;778-782.
7. Costa E., Guidotti A. Benzodiazepines on trial: a research strategy for their rehabilitation. Trends Pharmacol. Sci. 17:1996;192-199.
8. A receptors by imidazenil. In: Möhler, H., Da Prada, M. (Eds.), The Challenge of Neuropharmacology: A Tribute to the Memory of Willy Haefely. Roche, Basel, pp. 46-53.
9. Dazzi L., Motzo C., Imperato A., Serra M., Gessa G.L., Biggio G. The modulation of basal and stress-induced release of acetylcholine and dopamine in rat brain by abecarnil and imidazenil, two anxioselective gamma-aminobutyric acid A receptor modulators. J. Pharmacol. Exp. Ther. 273:1995;241-247.
10. Detouchi M., Costa E. Pentylenetetrazol convulsions and brain catecholamine turnover rate in rats and mice receiving diphenylhydantoin or benzodiazepines. Neuropharmacology. 12:1973;1059-1072.
11. During M.J., Spencer D.D. Extracellular hippocampal glutamate and spontaneous seizures in the conscious human brain. Lancet. 341:1993;1607-1610.
12. A channel conductance increased by diazepam. Nature. 388:1998;71-74.
13. Finlay J.M., Zigmond M.J., Abercrombie E.D. Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience. 64:1995;619-628.
14. Headley P.M., Grillner S. Excitatory amino acids and synaptic transmission: evidence for a physiological function. Trends Pharmacol. Sci. 11:1990;205.
15. Hiramatsu M., Kabuto H., Kwon M.J., Ishii A., Mori A. Depressed convulsions by diazepam and its effects on brain monoamines and amino acids in E1 mice. Epilepsy Res. 2(3):1988;183-186.
16. Hoogerkamp A., Arends R.H.G.P., Bomers A.M., Mandema J.W., Voskuyl R.A., Danhof M. Pharmacokinetic/pharmacodynamic relationship of benzodiazepines in the direct cortical stimulation model of anticonvulsant effect. J. Pharmacol. Exp. Ther. 279:1996;803-812.
17. Imperato A., Puglisi-Allegra S., Zocchi A., Scrocco M.G., Casolini P., Angelucci L. Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam. Eur. J. Pharmacol. 175(2):1990;211-214.
18. Imperato A., Dazzi L., Obinu M.C., Gessa G.L., Biggio G. The benzodiazepine receptor antagonist flumazenil increases acetylcholine release in rat hippocampus. Brain Res. 647:1994;167-171.
19. Invernizzi R., Pozzi L., Samanin R. Release of dopamine is reduced by diazepam more in nucleus accumbens than in the caudate nucleus of conscious rats. Neuropharmacology. 30(6):1991;575-578.
20. Ishizawa Y., Furuya K., Yamagishi S., Dohi S. Non-GABAergic effects of midazolam, diazepam, and flumazenil on voltage-dependent ion currents. NeuroReport. 8:1997;2635-2638.
21. Isokawa M., Mello L.E. NMDA receptor-mediated excitability in dendritically deformed dentate granule cells in pilocarpine-treated rats. Neurosci. Lett. 129:1988;69-73.
22. Kaneko S., Okada M., Hirano T., Kondo T., Otani K., Fukushima Y. Carbamazepine and zonisamide increase extracellular dopamine and serotonin levels in vivo, and carbamazepine does not antagonize adenosine effect in vitro. Mechanisms of blockade of seizure spread. Jpn. J. Psychiatr. Neurol. 47:1993;371-373.
23. Karreman M., Moghaddam B. The effect of a pharmacological stressor on glutamate efflux in the prefrontal cortex. Brain Res. 716(1-2):1996;180-182.
24. La Grutta V., Sabatino M. Substantia nigra-mediated anticonvulsant action: a possible role of a dopaminergic component. Brain Res. 515:1990;87-93.
25. La Grutta V., Sabatino M., Ferraro G., Liberti G., La Grutta G. Hippocampal seizures and striatal regulation: a possible functional pathway. Neurosci. Lett. 72:1986;277-282.
26. Lallement G., Carpenter P., Collet A., Pernot-Marino I., Baubichon D., Blanchet G. Effect of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus. Brain Res. 563:1991;234-240.
27. A receptors channels. Annu. Rev. Neurosci. 17:1994;569-602.
28. 2 muscarinic receptors. J. Pharmacol. Exp. Ther. 248:1996;1225-1260.
29. Marchi M., Bocchieri P., Garbarino L., Raiteri M. Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomes. Neurosci. Lett. 96:1989;229-234.
30. Marchi M., Sanguineti P., Raiteri M. Muscarinic receptors mediate direct inhibition of GABA release from rat striatal nerve terminals. Neurosci. Lett. 116:1990;347-351.
31. McLean M.J., Macdonald R.L. Benzodiazepines, but not beta carbolines, limit high frequency repetitive firing of action potentials of spinal cord neurons in cell culture. J. Pharmacol. Exp. Ther. 244:1987;789-795.
32. Meldrum B.S. Excitatory amino acids in epilepsy. Epilepsia. 32:1991;S1-3.
33. Meldrum B.S. The role of glutamate in epilepsy and other CNS disorders. Neurology. 44:1994;S14-S23.
34. Meyer J.S., Obara K., Muramatsu K. Diaschisis, review. Neurol. Res. 15:1993;362.
35. Millan M.H., Chapman A.G., Meldrum B.S. Extracellular amino acids levels in hippocampus during pilocarpine-induced seizures. Epilepsy Res. 14:1993;139-148.
36. Monmaur P. Phasic hippocampal activity during paradoxical sleep in the rat: selective suppression after diazepam administration. Experientia. 37:1981;261-262.
37. A- mediated inhibition induces synchronous epileptiform activity in immature rat hippocampus. Neuroscience. 82:1998;1067-1077.
38. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, San Diego, CA.
39. Phillis J.W., O'Regan M.H. Benzodiazepine interaction with adenosine system explains some anomalies in GABA hypothesis. Trends Pharmacol. Sci. 9:1988;153-154.
40. Raiteri M., Marchi M., Maura G. Presynaptic muscarinic receptors increase striatal dopamine release evoked by quasi-physiological depolarisation. Eur. J. Pharmacol. 83:1982;127-129.
41. Roberts E. Failure of GABAergic inhibition: a key to local and global seizures. Adv. Neurol. 44:1986;319-341.
42. Scatton B., Simon H., Le Moal M., Bischoff S. Origin of dopaminergic innervation of the rat hippocampal formation. Neurosci. Lett. 18:1980;125-131.
43. Shimuzu K., Matsubara K., Uezono T., Kimura K., Shiono H. Reduced dorsal hippocampal glutamate release significantly correlates with spatial memory deficits produced by benzodiazepines and ethanol. Neuroscience. 83:1998;701-706.
44. 1 receptor agonist, SKF 38393. Brain Res. 528:1987;148.
45. Smolders I., Sarre S., Ebinger G., Michotte Y. The analysis of excitatory, inhibitory, and other amino acids in rat brain microdialysates using microbore liquid chromatography. J. Neurosci. Meth. 57:1995;47-53.
46. Smolders I., Sarre S., Vanhaesensdonck C., Ebinger G., Michotte Y. Extracellular and striatal dopamine and glutamate after decortication and kainate receptor stimulation, as measured by microdialysis. J. Neurochem. 66:1996;2373-2380.
47. Smolders I., Khan G.M., Lindekens H., Prikken S., Marvin C.A., Manil J., Ebinger G., Michotte Y. Effectiveness of vigabatrin against focally evoked pilocarpine-induced seizures and concomitant changes in extracellular hippocampal and cerebellar glutamate, GABA and dopamine levels, a microdialysis-electrocorticography study in freely moving rats. J. Pharmacol. Exp. Ther. 283:1997;1239-1248.
48. Smolders I., Khan G.M., Manil J., Ebinger G., Michotte Y. NMDA receptor-mediated pilocarpine-induced seizures: characterization in freely moving rats by microdialysis. Br. J. Pharmacol. 121:1997;1171-1179.
49. Smolders I., Van Belle K., Ebinger G., Michotte Y. Hippocampal and cerebellar extracellular amino acids during pilocarpine-induced seizures in freely moving rats. Eur. J. Pharmacol. 319:1997;21-29.
50. Starr M.S. The role of dopamine in epilepsy. Synapse. 22:1996;159-194.
51. Stancheva S., Petkov V.V. Effects of chronic diazepam and medazepam treatment of biogenic monoamines in different rat brain areas. Acta Physiol. Pharmacol. Bulg. 14(3):1988;26-31.
52. Suppes T., Kriegstein A.R., Prince D.A. The influence of dopamine on epileptiform burst activity in hippocampal pyramidal neurons. Brain Res. 326:1985;273-280.
53. Turski L., Ikonomidou C., Turski W.A., Bortolotto Z.A., Cavalheiro E.A. Cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental method of intractable epilepsy. Synapse. 3:1989;154-171.
54. Verney C., Baulac M., Berger B., Alvarez C., Vigny A., Helle K.B. Morphological evidence for a dopaminergic terminal field in the hippocampal formation of young and adult rat. Neuroscience. 14:1985;1039-1052.
55. Wade J.V., Samson F.E., Nelson S.R., Pazdernik T.L. Changes in extracellular amino acids during soman- and kainic acid-induced seizures. J. Neurochem. 49:1987;645-650.
56. Whitton P.S., Biggs C.S., Pearce B.R., Fowler L.J. Regional effects of MK 801 suppression after diazepam administration on dopamine and its metabolites studied by in vivo microdialysis. Neurosci. Lett. 142:1992;5-8.
57. Zetterström T., Fillenz M. Local administration of flurazepam has different effects on dopamine release in striatum and nucleus accumbens: a microdialysis study. Neuropharmacology. 29:1990;129-134.